Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
levetiracetam, Quantity: 500 mg
Strides Pharma Science Pty Ltd
Levetiracetam
Tablet, film coated
Excipient Ingredients: iron oxide yellow; crospovidone; hypromellose; colloidal anhydrous silica; purified talc; povidone; titanium dioxide; macrogol 400; magnesium stearate
Oral
60 tablets, 100 tablets, 10 tablets
(S4) Prescription Only Medicine
Levetiracetam film-coated tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation, ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME), and ? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).
Visual Identification: Yellow colour, oval shaped film coated tablets with break line on one side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-04-17